期刊文献+

外周T细胞淋巴瘤患者中PD-1的表达对CD45RA^+、CD45RO^+T细胞的影响 被引量:5

The relationship between PD-1 expression and CD45RA^+ and CD45RO^+ T cells in peripheral T cell lymphoma patients
下载PDF
导出
摘要 目的:探讨外周T细胞淋巴瘤(PTCL)患者淋巴瘤组织中PD-1的表达与外周血中初始和记忆T细胞水平的关系。方法:20例PTCL患者采用免疫组化法检测淋巴瘤组织中PD-1的表达,采用流式细胞术检测CHOP方案化疗前后外周血中CD4^+CD45RA^+、CD4^+、CD45RO^+、CD8^+CD45RA^+和CD8^+CD45RO^+T细胞的比例,分析PD-1的表达与T细胞亚群的关系。结果:PD-1、PD-L1蛋白在PTCL患者中表达升高,PD-1阳性患者疗效较差。PD-1阳性患者中CD4^+T细胞、CD8^+T细胞明显低于PD-1阴性患者;PD-1阴性组患者CD4^+CD45RO^+、CD8^+CD45RA^+、CD8^+CD45RO^+T细胞明显高于PD-1阳性患者,差异有统计学意义。结论:PTCL患者中存在PD-1/PD-L1蛋白的表达异常,PD-1阳性患者存在更明显的T细胞免疫功能缺陷。 Objective To investigate the relationship between the expression of PD -1 in lymphoid tissue and the level of initial and memory T cells in peripheral blood in peripheral T cell lymphoma (PTCL) patients. Methods: The expression of PD - 1 was detected by immunohistochemistry in lymphoma tissue in 20 PTCL patients. The proportion of CD4 + CD45RA+ ,CD4 + CD45RO+ ,CD8 + CD45RA+ and CD8 + CD45RO + T cells before and after CHOP chemo-therapy in peripheral blood in 20 PTCL patients were detected by flow cytometry. The relationship between expression of PD - 1 and T cell subsets was analysed. Results : The expression of PD - 1 and PD - LI protein were increased in PTCL patients, and PD -1 positive patients had poor curative effect. The CD4 + T cells and CD8 + T cells in PD - 1 positive patients were significantly lower than that of PD - 1 negative group. The CD4 + CD45RO + , CD8 + CD45RA + and CD8 + CD45RO + T cells in the PD - 1 negative group were significantly higher than those in the PD - 1 positive group, the difference was statistically significant. Conclusion: The expression of PD - 1/PD - LI protein in patients with PTCL is abnormal, and the PD -1 positive patients have more obvious defects in T cell immune function.
出处 《现代肿瘤医学》 CAS 2017年第10期1643-1646,共4页 Journal of Modern Oncology
基金 广东省医学科学技术研究基金项目(编号:B2015039)
关键词 外周T细胞淋巴瘤 PD-1 CHOP方案 初始T细胞 记忆T细胞 ] peripheral T cell lymphoma, PD - 1, CHOP, naive T cells,memory T cells
  • 相关文献

参考文献5

二级参考文献63

  • 1张晶,谢幸,叶大风.黏附分子与肿瘤免疫逃逸[J].实用肿瘤杂志,2004,19(5):449-452. 被引量:18
  • 2王晋芬,王云中,陈振文,Taylor Clive R.根据WHO淋巴造血系统肿瘤新分类对山西省淋巴瘤分布特点的分析[J].中华病理学杂志,2006,35(4):218-223. 被引量:24
  • 3Dong HD,Zhu GF,Tamada K,et al. B7-H1,a third member ofthe B7 family,co-stimulates T-cell proliferation and interieukin-lOsecretion. Nat Med,1999; 5(12) :1365 -1369.
  • 4Dong H,Strome SE,Salomao DR,et al. Tumor-associated B7-H1promotes T-cell apoptosis :A potential mechanism of immuneevasion. Nat Med,2002; 8(8) :793 -800.
  • 5Gottesman MM. Mechanisms of cancer drug resistance. Ann RevMed,2002 ; 53:615 -627.
  • 6Ramp U,Dejosez M,Mahotka C,et al. Deficient activation ofCD95 ( APO-1/Fas ) -mediated apoptosis :a potential factor ofmultidrug resistance in human renal cell carcinoma. Br J Cancer,2000 ; 82(11) :1851 -1859.
  • 7Friesen C,Fulda S,Debatin KM. Deficient activation of the CD95(APO-1/Fas) system in drug-resistant cells. Leukemia,1997; 11(U):1833 -1841.
  • 8Vucic D,Stennicke HR,Pisabarro MT,et al. ML-IAP,a novelinhibitor of apoptosis that is preferentially expressed in humanmelanomas. Curr Biol,2000; 10(21) ; 1359 - 1366.
  • 9Adams JM,Cory S. The Bel-2 apoptotic switch in cancerdevelopment and therapy. Oncogene,2007 ; 26(9) :1324 -1337.
  • 10Dive C. Avoidance of apoptosis as a mechanism of drug resistance.J Intern Med Suppl,1997 ; 740:139-145.

共引文献307

同被引文献37

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部